NCT06169371View on ClinicalTrials.gov

Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)

PHASE4RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 28, 2023

Primary Completion Date

November 30, 2030

Study Completion Date

November 30, 2030

Conditions
Breast Cancer
Interventions
DRUG

Abemaciclib

Week 1 50mg orally BID

DRUG

Abemaciclib

Week 2 100mg orally BID

DRUG

Abemaciclib

Week 3+ 150mg orally BID

Trial Locations (2)

52242

RECRUITING

Iowa Holden Comprehensive Cancer Center, Iowa City

60612

RECRUITING

University of Illinois, Chicago

All Listed Sponsors
lead

University of Illinois at Chicago

OTHER